Combinatorial treatment with donafenib and quercetin suppresses lipid metabolism in HepG2 cells by targeting the CREB1/DRP1/SREBP1 axis | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Combinatorial treatment with donafenib and quercetin suppresses lipid metabolism in HepG2 cells by targeting the CREB1/DRP1/SREBP1 axis

Authors:: Lei Xiang; Jinjie Shi; Xueqing Huang; Shi Zhou

Reference:: Translational Cancer Research; 2026; 15; 97

DOI:: 10.21037/tcr-2025-aw-2393

See Abstract

Key Words:: Hepatocellular carcinoma; HepG2; donafenib; quercetin; CREB1/DRP1/SREBP1; mice; animal experiments

Back to index